Vanguard Portfolio Management LLC has amended its Schedule 13G filing, revealing it holds 1,741,113 shares of Inspire Medical Systems, Inc., which accounts for 6.02% of the company. This amendment, filed on October 30, 2026, signifies Vanguard's ongoing investment in the surgical and medical instruments industry, reflecting its substantial influence in the market.

Inspire Medical Systems, Inc. is a company focused on surgical and medical instruments and apparatus. The company is based in Minneapolis, Minnesota, and was incorporated in Delaware. Its Central Index Key (CIK) is 0001609550, and it operates under the SIC code for surgical and medical instruments and apparatus.

The recent filing indicates that Vanguard Portfolio Management has sole voting power over 36,509 shares and sole dispositive power over the total of 1,741,113 shares. This information highlights Vanguard's significant role in shaping the future of Inspire Medical Systems.

This update may affect various stakeholders, including investors and analysts monitoring Inspire Medical Systems and the surgical and medical instruments industry. Vanguard's substantial stake could influence the company's strategic decisions and market performance.

The filing does not say what happens next regarding Vanguard's investment strategy or any potential actions related to Inspire Medical Systems.

The filing also discloses that Vanguard Portfolio Management LLC has sole dispositive power over all 1,741,113 shares, indicating a strong level of control over its investment in Inspire Medical Systems. Additionally, Vanguard's investment is classified under the SEC's Rule 13d-1(b), which pertains to institutional investment managers.

Furthermore, the filing specifies that Vanguard Portfolio Management is incorporated in Pennsylvania and has its principal business office located at 100 Vanguard Blvd, Malvern, PA. This strategic location is significant as it positions Vanguard within a key financial hub.

Importantly, the filing notes that Vanguard Portfolio Management, including its affiliates such as Vanguard Fiduciary Trust Company and Vanguard Global Advisers, LLC, exercises investment discretion over the reported shares. This means that these entities may influence investment decisions on behalf of their clients, reflecting a collaborative approach within Vanguard's investment management framework.

While the filing provides substantial details regarding Vanguard's holdings and voting power, it does not elaborate on any specific future plans or strategies related to Inspire Medical Systems, leaving stakeholders to speculate on Vanguard's intentions moving forward.